The Commission is anticipated to approve different vaccines within the coming weeks and months. Vincent Kalut / Photonews by way of Getty Images

The EU has secured entry to 300 million extra doses of Pfizer and BioNTech’s COVID-19 vaccine, the European Commission president Ursula von der Leyen mentioned Friday morning.

If it orders all 300 million doses, this is able to double its complete provide of the shot.

The EU has confronted criticism for its sluggish vaccine rollout however ordering extra doses is unlikely to resolve the issue, resulting from provide issues and sluggish distribution.

Visit Business Insider’s homepage for extra tales.

The EU has secured entry to 300 million extra doses of Pfizer and BioNTech’s COVID-19 vaccine, the president of the European Commission, Ursula von der Leyen, mentioned throughout a press convention Friday morning.

This would double the EU’s complete provide of Pfizer-BioNTech’s vaccine, however is unlikely to resolve issues with the commerce bloc’s sluggish rollout of vaccines.

The Commission proposed buying an additional 200 million further doses to EU member states, with the choice to accumulate one other 100 million doses, it mentioned Friday.

Of the 300 million further doses, 75 million will likely be obtainable from the second quarter of 2021, von der Leyen mentioned. The remaining 225 million doses will likely be delivered within the latter half of the yr, she mentioned.

For its preliminary 300 million doses, which have been introduced in 2020, the EU had agreed to pay Pfizer-BioNTech 12 euros ($14.71) per dose of its vaccine, in accordance with a tweet by a Belgian politician.

Alongside Moderna’s vaccine, which the European medicine regulator approved on Wednesday, the EU will have already entry to sufficient doses of the 2 accredited photographs to immunize 80% of its inhabitants, von der Leyen mentioned.

The Commission is anticipated to approve different vaccines within the coming weeks and months, she added.

Read extra: Inside Moderna’s historic coronavirus vaccine program that remodeled the biotech upstart right into a $55 billion drug business powerhouse

The EU has confronted criticism for its sluggish vaccine rollout. But ordering extra doses is unlikely to resolve the issue.

Story continues

EU officers mentioned the sluggish rollout stems not from the variety of doses however the availability of them due to manufacturing delays, alongside the truth that international locations have already been sluggish to manage them.

“We have to raise the numbers of vaccinations rapidly,” von der Leyen mentioned throughout Friday’s press convention, and international locations have to “step up.”

According to figures obtained by Our World in Data on Thursday, Denmark, the EU state with the very best COVID-19 vaccination charge, has solely given the primary shot to 1.43% of its inhabitants. Every EU member state has vaccinated a smaller proportion of its inhabitants that the US, which has vaccinated round 1.79% of residents.

France’s rollout has been notably sluggish, with solely round 50,000 individuals out of its roughly 67 million inhabitants receiving the shot in its first week of rollout in comparison with 200,000 in Germany. This is being additional exacerbated by the inhabitants’s hesitancy to take the vaccine.

“The current government generated a huge amount of distrust over its management of the COVID crisis, and that’s reflected towards the vaccine,” Florian Cafiero, a sociologist on the National Centre for Scientific Research, informed the BBC.

During the press briefing, von der Leyen additionally praised the extensive portfolio of vaccines that the EU has secured with six drugmakers, totaling as much as 2.3 billion doses. She additionally mentioned the significance of vaccinating the broader European neighborhood past simply the 27 EU member states.

“We’re only safe when everyone in Europe has access to a vaccine, and our neighbors, too” she added. “Only together can we come out of this deep health and economic crisis.”

The doses secured by the EU would allow it to “not only to cover the needs of its whole population, but also to supply vaccines to neighbouring countries,” the Commission mentioned.

Read the unique article on Business Insider



Source hyperlink